{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T16:00:41Z","timestamp":1708012841901},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,16]]},"DOI":"10.7759\/cureus.19619","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T10:22:22Z","timestamp":1637058142000},"source":"Crossref","is-referenced-by-count":1,"title":["Primary Leptomeningeal B-cell Lymphoma in an Immunocompetent Adult: Case Report"],"prefix":"10.7759","author":[{"given":"Andrea","family":"Calderon-Castro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Enciso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Tejada-Cabrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.41.1.95","article-title":"Primary leptomeningeal lymphoma. Report of 9 cases, diagnosis with immunocytochemical analysis, and review of the literature","volume":"41","author":"Lachance DH","year":"1991","unstructured":"Lachance DH, O'Neill BP, Macdonald DR, Jaeckle KA, Witzig TE, Li CY, Posner JB. Primary leptomeningeal lymphoma. Report of 9 cases, diagnosis with immunocytochemical analysis, and review of the literature. Neurology. 1991, 41:95-100. 10.1212\/wnl.41.1.95","journal-title":"Neurology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000435302.02895.f3","article-title":"Primary leptomeningeal lymphoma. International Primary CNS Lymphoma Collaborative Group report","volume":"81","author":"Taylor JW","year":"2013","unstructured":"Taylor JW, Flanagan EP, O'Neill BP, et al.. Primary leptomeningeal lymphoma. International Primary CNS Lymphoma Collaborative Group report. Neurology. 2013, 81:1690-6. 10.1212\/01.wnl.0000435302.02895.f3","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2013.606","article-title":"A systematic approach to the diagnosis of suspected central nervous system lymphoma","volume":"70","author":"Scott BJ","year":"2013","unstructured":"Scott BJ, Douglas VC, Tihan T, Rubenstein JL, Josephson SA. A systematic approach to the diagnosis of suspected central nervous system lymphoma. JAMA Neurol. 2013, 70:311-9. 10.1001\/jamaneurol.2013.606","journal-title":"JAMA Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2221-3","article-title":"The dubious value of cerebrospinal fluid adenosine deaminase measurement for the diagnosis of tuberculous meningitis","volume":"17","author":"Ekermans P","year":"2017","unstructured":"Ekermans P, Dus\u00e9 A, George J. The dubious value of cerebrospinal fluid adenosine deaminase measurement for the diagnosis of tuberculous meningitis. BMC Infect Dis. 2017, 17:104. 10.1186\/s12879-017-2221-3","journal-title":"BMC Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2019.09.078","article-title":"Adenosine deaminase inhibition","volume":"141","author":"Bagheri S","year":"2019","unstructured":"Bagheri S, Saboury AA, Haertl\u00e9 T. Adenosine deaminase inhibition. Int J Biol Macromol. 2019, 141:1246-57. 10.1016\/j.ijbiomac.2019.09.078","journal-title":"Int J Biol Macromol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00247-010-1673-z","article-title":"Primary leptomeningeal central nervous system lymphoma in an immunocompetent adolescent: an unusual presentation","volume":"40 Suppl 1","author":"Jordaan MR","year":"2010","unstructured":"Jordaan MR, Prabhu SP, Silvera VM. Primary leptomeningeal central nervous system lymphoma in an immunocompetent adolescent: an unusual presentation. Pediatr Radiol. 2010, 40 Suppl 1:S141-4. 10.1007\/s00247-010-1673-z","journal-title":"Pediatr Radiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(16)00036-3","article-title":"Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: Results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial","volume":"3","author":"Ferreri AJM","year":"2016","unstructured":"Ferreri AJM, Cwynarski K, Pulczynski E, et al.. Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: Results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial. Lancet Haematol. 2016, 3:e217-27. 10.1016\/S2352-3026(16)00036-3","journal-title":"Lancet Haematol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(17)30174-6","article-title":"Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 Phase 2 trial","volume":"4","author":"Ferreri AJM","year":"2017","unstructured":"Ferreri AJM, Cwynarski K, Pulczynski E, et al.. Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 Phase 2 trial. Lancet Haematol. 2017, 4:e510-23. 10.1016\/S2352-3026(17)30174-6","journal-title":"Lancet Haematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2017.1.565","article-title":"Therapy of primary CNS lymphoma: role of intensity, radiation, and novel agents","volume":"2017","author":"Ferreri AJ","year":"2017","unstructured":"Ferreri AJ. Therapy of primary CNS lymphoma: role of intensity, radiation, and novel agents. Hematology Am Soc Hematol Educ Program. 2017, 2017:565-77. 10.1182\/asheducation-2017.1.565","journal-title":"Hematology Am Soc Hematol Educ Program"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/76569-primary-leptomeningeal-b-cell-lymphoma-in-an-immunocompetent-adult-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:36:18Z","timestamp":1707507378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/76569-primary-leptomeningeal-b-cell-lymphoma-in-an-immunocompetent-adult-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,16]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.19619","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,16]]}}}